Global Geriatric Medicines Market 2023-2027

Description

List of Tables

The geriatric medicines market is forecasted to grow by USD 44.85 bn during 2022-2027, accelerating at a CAGR of 6.81% during the forecast period. The report on the geriatric medicines market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, demand for personalized medicine, and an increase in government and NGO supports for the elderly.

Technavio's geriatric medicines market is segmented as below:

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Type

Analgesics
Antidiabetics
Antihypertensives
Statins
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rise in therapeutic approaches as one of the prime reasons driving the geriatric medicines market growth during the next few years. Also, strategic partnerships and acquisitions and active role-play of senior citizens in monitoring their health remotely will lead to sizable demand in the market.

The report on the geriatric medicines market covers the following areas:

Geriatric medicines market sizing
Geriatric medicines market forecast
Geriatric medicines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading geriatric medicines market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Sanofi. Also, the geriatric medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75472

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global geriatric medicines market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global geriatric medicines market 2017 - 2021 ($ billion)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
6.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Analgesics - Market size and forecast 2022-2027
Exhibit 52: Chart on Analgesics - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Analgesics - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Analgesics - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Analgesics - Year-over-year growth 2022-2027 (%)
7.4 Antidiabetics - Market size and forecast 2022-2027
Exhibit 56: Chart on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Antidiabetics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Antidiabetics - Year-over-year growth 2022-2027 (%)
7.5 Antihypertensives - Market size and forecast 2022-2027
Exhibit 60: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
7.6 Statins - Market size and forecast 2022-2027
Exhibit 64: Chart on Statins - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Statins - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Statins - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Statins - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Type
Exhibit 72: Market opportunity by Type ($ billion)
Exhibit 73: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 111: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key offerings
Exhibit 126: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 127: AbbVie Inc. - Overview
Exhibit 128: AbbVie Inc. - Product / Service
Exhibit 129: AbbVie Inc. - Key news
Exhibit 130: AbbVie Inc. - Key offerings
12.5 AstraZeneca PLC
Exhibit 131: AstraZeneca PLC - Overview
Exhibit 132: AstraZeneca PLC - Product / Service
Exhibit 133: AstraZeneca PLC - Key news
Exhibit 134: AstraZeneca PLC - Key offerings
12.6 Boehringer Ingelheim International GmbH
Exhibit 135: Boehringer Ingelheim International GmbH - Overview
Exhibit 136: Boehringer Ingelheim International GmbH - Business segments
Exhibit 137: Boehringer Ingelheim International GmbH - Key news
Exhibit 138: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 139: Boehringer Ingelheim International GmbH - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 140: Bristol Myers Squibb Co. - Overview
Exhibit 141: Bristol Myers Squibb Co. - Product / Service
Exhibit 142: Bristol Myers Squibb Co. - Key news
Exhibit 143: Bristol Myers Squibb Co. - Key offerings
12.8 Dr Reddys Laboratories Ltd.
Exhibit 144: Dr Reddys Laboratories Ltd. - Overview
Exhibit 145: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 146: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 147: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Eli Lilly and Co.
Exhibit 148: Eli Lilly and Co. - Overview
Exhibit 149: Eli Lilly and Co. - Product / Service
Exhibit 150: Eli Lilly and Co. - Key news
Exhibit 151: Eli Lilly and Co. - Key offerings
12.10 Endo International Plc
Exhibit 152: Endo International Plc - Overview
Exhibit 153: Endo International Plc - Business segments
Exhibit 154: Endo International Plc - Key news
Exhibit 155: Endo International Plc - Key offerings
Exhibit 156: Endo International Plc - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 157: GlaxoSmithKline Plc - Overview
Exhibit 158: GlaxoSmithKline Plc - Business segments
Exhibit 159: GlaxoSmithKline Plc - Key news
Exhibit 160: GlaxoSmithKline Plc - Key offerings
Exhibit 161: GlaxoSmithKline Plc - Segment focus
12.12 Merck and Co. Inc.
Exhibit 162: Merck and Co. Inc. - Overview
Exhibit 163: Merck and Co. Inc. - Business segments
Exhibit 164: Merck and Co. Inc. - Key news
Exhibit 165: Merck and Co. Inc. - Key offerings
Exhibit 166: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 167: Novartis AG - Overview
Exhibit 168: Novartis AG - Business segments
Exhibit 169: Novartis AG - Key offerings
Exhibit 170: Novartis AG - Segment focus
12.14 Otsuka Holdings Co. Ltd.
Exhibit 171: Otsuka Holdings Co. Ltd. - Overview
Exhibit 172: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 173: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 174: Otsuka Holdings Co. Ltd. - Segment focus
12.15 Pfizer Inc.
Exhibit 175: Pfizer Inc. - Overview
Exhibit 176: Pfizer Inc. - Product / Service
Exhibit 177: Pfizer Inc. - Key news
Exhibit 178: Pfizer Inc. - Key offerings
12.16 Sanofi
Exhibit 179: Sanofi - Overview
Exhibit 180: Sanofi - Business segments
Exhibit 181: Sanofi - Key news
Exhibit 182: Sanofi - Key offerings
Exhibit 183: Sanofi - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 184: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 185: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 186: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 187: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 188: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 189: Inclusions checklist
Exhibit 190: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 191: Currency conversion rates for US$
13.4 Research methodology
Exhibit 192: Research methodology
Exhibit 193: Validation techniques employed for market sizing
Exhibit 194: Information sources
13.5 List of abbreviations
Exhibit 195: List of abbreviations